Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma
Abstract Optic neuropathies such as glaucoma are characterized by retinal ganglion cell (RGC) degeneration and death. The sigma-1 receptor (S1R) is an attractive target for treating optic neuropathies as it is highly expressed in RGCs, and its absence causes retinal degeneration. Activation of the S...
Guardado en:
Autores principales: | Michal Geva, Noga Gershoni-Emek, Luana Naia, Philip Ly, Sandra Mota, Ana Cristina Rego, Michael R. Hayden, Leonard A. Levin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca78b753223b4e7397379916ee16da40 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Retinal ganglion cell protection by hop-flower extract as a novel neuroprotective strategy for glaucoma
por: Tomoko Hasegawa, et al.
Publicado: (2022) -
Cell-Based Neuroprotection of Retinal Ganglion Cells in Animal Models of Optic Neuropathies
por: Yue Hu, et al.
Publicado: (2021) -
Current perspective of neuroprotection and glaucoma
por: Tian K, et al.
Publicado: (2015) -
Hop flower extracts mitigate retinal ganglion cell degeneration in a glaucoma mouse model
por: Tomoko Hasegawa, et al.
Publicado: (2020) -
PERG adaptation for detection of retinal ganglion cell dysfunction in glaucoma: a pilot diagnostic accuracy study
por: T. Salgarello, et al.
Publicado: (2021)